Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Meneghini

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Clinical Immunology (Orlando, Fla.)|March 19, 2011
Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetesDongmei Han, Carlos A Leyva, Della Matheson, et al.
International Journal of Immunopathology and Pharmacology|June 3, 2004
Interleukin-28 and 29 (IL-28 and IL-29): new cytokines with anti-viral activitiesD Kempuraj, J Donelan, S Frydas, et al.
Postgraduate Medicine|October 4, 2016
Achieve control: a pragmatic clinical trial of insulin glargine 300 U/mL versus other basal insulins in insulin-naïve patients with type 2 diabetesGerry Oster, Sean D Sullivan, Mehul R Dalal, et al.
Diabetes, Obesity & Metabolism|July 27, 2012
The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countriesK Khunti, S Caputo, T Damci, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Clinical Immunology (Orlando, Fla.)|March 19, 2011
Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetesDongmei Han, Carlos A Leyva, Della Matheson, et al.
International Journal of Immunopathology and Pharmacology|June 3, 2004
Interleukin-28 and 29 (IL-28 and IL-29): new cytokines with anti-viral activitiesD Kempuraj, J Donelan, S Frydas, et al.
Postgraduate Medicine|October 4, 2016
Achieve control: a pragmatic clinical trial of insulin glargine 300 U/mL versus other basal insulins in insulin-naïve patients with type 2 diabetesGerry Oster, Sean D Sullivan, Mehul R Dalal, et al.
Diabetes, Obesity & Metabolism|July 27, 2012
The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countriesK Khunti, S Caputo, T Damci, et al.
Pageof 9